ekonominyheter

TranslateRSSMobil
Bristol-Myers Signs Option Agreement to Buy Galecto

Bristol-Myers Signs Option Agreement to Buy Galecto

Wall Street Journal 3/11 11:18

Bristol-Myers Squibb said it has signed an option agreement to buy Galecto Biotech and its experimental pulmonary fibrosis treatment in a deal that could be valued at up to $444 million.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status